Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 13, 2023 08:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Announces $8 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SAN DIEGO, June 13, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery (“Biora” or the “Company”), today announced that it...
June 08, 2023 09:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics to Present Preclinical Data on the BioJet™ Systemic Oral Delivery Platform at the 59th Annual Meeting of the European Association for the Study of Diabetes

SAN DIEGO, June 08, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will present preclinical...
May 15, 2023 16:05 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results

Completed execution of toxicology study for NaviCap™ BT-600 program with no adverse events indicated in preliminary data; on track to file IND in Q3 2023 Preclinical testing for the BioJet™ platform...
May 08, 2023 09:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics to Report First Quarter 2023 Financial Results and Provide Corporate Update

SAN DIEGO, May 08, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will report first quarter...
May 01, 2023 09:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Appoints Dr. Ariella Kelman as Chief Medical Officer

SAN DIEGO, May 01, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced the appointment of Ariella Kelman,...
April 20, 2023 16:46 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics to Participate in Crohn’s & Colitis Foundation’s IBD Innovate Conference

SAN DIEGO, April 20, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will participate in IBD...
March 30, 2023 16:01 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results

Biora initiating preclinical testing with pharma collaborator’s molecule following recent data exceeding the company’s target bioavailability levels for systemic therapeutics platform No adverse...
March 23, 2023 09:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update

SAN DIEGO, March 23, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will report fourth...
February 23, 2023 09:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Announces Bioavailability Results for Oral Delivery of GLP-1 Receptor Agonist

SAN DIEGO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced preliminary results from...
February 16, 2023 09:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Announces Improved Bioavailability Results for its Systemic Delivery Platform

SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced preliminary results from...